Connection

Philip Howe to DNA

This is a "connection" page, showing publications Philip Howe has written about DNA.
Connection Strength

0.757
DNA
  1. Heterogeneous nuclear ribonucleoprotein E1 binds polycytosine DNA and monitors genome integrity. Life Sci Alliance. 2021 09; 4(9).
    View in: PubMed
    Score: 0.612
  2. Wnt signaling: physiology and pathology. Growth Factors. 2004 Sep; 22(3):141-50.
    View in: PubMed
    Score: 0.048
  3. Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus. J Autoimmun. 2022 07; 131:102860.
    View in: PubMed
    Score: 0.041
  4. Caspase inhibitor BD-fmk distinguishes transforming growth factor beta-induced apoptosis from growth inhibition. Cell Growth Differ. 1998 Oct; 9(10):869-75.
    View in: PubMed
    Score: 0.032
  5. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. J Biol Chem. 2003 Jul 11; 278(28):26249-57.
    View in: PubMed
    Score: 0.011
  6. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem. 1996 Jul 26; 271(30):17791-7.
    View in: PubMed
    Score: 0.007
  7. Interferon alpha/beta modulation of growth-factor-stimulated mitogenicity in AKR-2B fibroblasts. J Cell Physiol. 1989 Dec; 141(3):453-60.
    View in: PubMed
    Score: 0.004
  8. The regulation of cell proliferation by serum growth factors. Ann N Y Acad Sci. 1982 Dec 10; 397:1-10.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.